Prevention and reversal by enalapril of target organ damage in angiotensin II hypertension

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 6, Issue 3, 2005, Pages 154-160

  Rugale, Caroline ^a   Cordaillat, Magali ^a   Mimran, Albert ^a   Jover, Bernard ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

ACE inhibitors (ACES Is); Cardiac hypertrophy; NADPH oxidase; Oxidative stress; Proteinuria

Indexed keywords

ANGIOTENSIN II; APOCYNIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FREE RADICAL; POTASSIUM; REACTIVE OXYGEN METABOLITE; SODIUM; SUPEROXIDE;

ALBUMINURIA; ANIMAL CELL; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR PARAMETERS; CAROTID ARTERY; CHEMICAL ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; HEART HYPERTROPHY; HEART WEIGHT; HYPERTENSION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN METABOLISM; RAT; TARGET ORGAN;

ACETOPHENONES; ALBUMINURIA; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DISEASE MODELS, ANIMAL; ENALAPRIL; HYPERTENSION; MALE; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

EID: 33144471520     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2005.023     Document Type: Article

References (29)

1. Lee RMKW, Berecek KH, Tsoporis J, McKenzie R, Triggle CR. Prevention of hypertension and vascular changes by captopril treatment. Hypertension 1991;17:141-50.
2. Linz W, Schaper J, Wiemer G, Albus U, Schölkens BA. Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats. Br J Pharmacol 1992;107:970-5.
3. Herizi A, Demeillers B, Jover B, Mimran A. Cardioprotective effect of enalapril in renovascular and angiotensin II hypertension. Clin Exp Hypertens 1997;19:953-64.
4. Anderson S, Rennke HG, Brenner BM. Nifedipine versus fosinopril in uninephrectomized diabetic rats. Kidney Int 1992;41:891-7.
5. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993;329:1456-62.
6. Sadoshima JI, Izumo S. Molecular characterization of angiotensin-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of AT1 receptor subtype. Circ Res 1993;73:413-23.
7. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 1995;95:588-93.
8. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994;74:1141-8.
9. Wolf G. Free radical production and angiotensin. Curr Hypertens Rep 2000;66:167-73.
10. Delbosc S, Cristol JP, Descomps B, Mimran A, Jover B. Simvastatin prevents angiotensin II-induced cardiac alterations and oxidative stress. Hypertension 2002;40:142-7.
11. Rugale C, Delbosc S, Cristol JP, Mimran A, Jover B. Sodium restriction prevents cardiac hypertrophy and oxidative stress in angiotensin II hypertension. Am J Physiol Heart Circ Physiol 2003;284:H1744-50.
12. Dostal DE, Baker KM. Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart: mediation by the AT1 receptor. Am J Hypertens 1992;5:276-80.
13. Kim S, Ohta K, Hamaguchi A et al. Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats. Hypertension 1994;24:195-204.
14. Zou LX, Imig HK, Von Thun AM, Hymel A, Ono H, Navar LG. Receptor-mediated intrarenal angiotensin II augmentation in angiotensin II-infused rats. Hypertension 1996;28:669-77.
15. Raasch W, Bartels T, Schwartz C, Häuser W, Rütten H, Dominiak P. Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors? J Hypertens 2002;20:2495-504.
16. Wu R, Laplante MA, de Champlain J. Prevention of angiotensin II-induced hypertension, cardiovascular hypertrophy and oxidative stress by acetylsalicylic acid in rats. J Hypertens 2004;22:793-801.
17. Ungvari Z, Csiszar A, Kaminski PM, Wolin MS, Koller A. Chronic high pressure-induced arterial oxidative stress. Involvement of protein kinase C-dependent NAD(P)H oxidase and local renin-angiotensin system. Am J Pathol 2004; 165:219-26.
18. Lee C, Miura K, Liu X, Zweier JL. Biphasic regulation of leucocyte superoxide generation by nitric oxide and peroxinitrite. J Biol Chem 2000;275:38965-72.
19. Ritchie RH, Schiebinger RJ, Lapointe MC, Marsh JD. Angiotensin II-induced hypertrophy of adult rat cardiomyocytes is blocked by nitric oxide. Am J Physiol Heart Circ Physiol 1998;275:H1370-4.
20. De Cavanagh EMV, Inserra F, Toblli J, Stella I, Fraga CG, Ferder L. Enalapril attenuates oxidative stress in diabetic rats. Hypertension 2001;38:1130-6.
21. Metsarinne KP, Helin KH, Saijonmaa O, Stewen P, Sirvio ML, Fyhrquist FY. Tissue-specific regulation of angiotensin-converting enzyme by angiotensin II and losartan in the rat. Blood Pressure 1996;5:363-70.
22. Zhuo JL, Imig JD, Hammond TG, Orengo S, Benes E, Navar LG. Ang II accumulation in rat renal endosomes during Ang II-induced hypertension. Role of AT1 receptor. Hypertension 2002;39:116-21.
23. Von Thun AM, Vari RC, El-Dahr SS, Navar LG. Augmentation of intrarenal angiotensin II levels by chronic angiotensin II infusion. Am J Physiol (Renal Fluid Electrolyte Physiol 35) 1994;266:F120-28.
24. Kobori H, Harrison-Bernard LM, Navar LG. Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension. J Am Soc Nephrol 2001;12:431-9.
25. Harrison-Bernard LM, Zhuo J, Kobori H, Ohishi M, Navar LG. Intrarenal AT1 receptor and ACE binding in ANG II-induced hypertensive rats. Am J Physiol Renal Physiol 2002; 281:F19-25.
26. Campbell DJ, Kladis A, Duncan AM. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension 1994;23:439-49.
27. Linz W, Scholkens BA. A specific B2-bradykinin receptor antagonist Hoe140 abolishes the antihypertrophic effect of ramipril. Br J Pharmacol 1992;105:771-2.
28. Hutchison FN, Cui X, Webster SK. The antiproteinuric action of angiotensin-converting enzyme is dependent on kinin. J Am Soc Nephrol 1995;6:1216-22.
29. Pasquie JL, Herizi A, Jover B, Mimran A. Chronic bradykinin infusion and receptor blockade in angiotensin II hypertension in rats. Hypertension 1999;33:830-4.